-
Table of Contents
How Diidroboldenone Cipionato Affects Liver Enzymes (ALT, AST)
Diidroboldenone cipionato, also known as DHB cipionato, is a synthetic anabolic androgenic steroid (AAS) that is commonly used by athletes and bodybuilders to enhance muscle growth and performance. However, like many other AAS, it has been found to have potential side effects on the liver, specifically on liver enzymes ALT (alanine aminotransferase) and AST (aspartate aminotransferase). In this article, we will explore the effects of DHB cipionato on liver enzymes and the potential risks associated with its use.
The Pharmacokinetics of DHB Cipionato
DHB cipionato is a modified form of the AAS boldenone, with an added cypionate ester. This modification allows for a slower release of the hormone into the body, resulting in a longer half-life and a longer duration of action. DHB cipionato is typically administered via intramuscular injection and has a half-life of approximately 8 days.
Once injected, DHB cipionato is metabolized by the liver and converted into its active form, dihydroboldenone. This active form then binds to androgen receptors in various tissues, including muscle tissue, promoting protein synthesis and muscle growth. However, as with any AAS, DHB cipionato can also have effects on other tissues, including the liver.
The Effects of DHB Cipionato on Liver Enzymes
Studies have shown that the use of DHB cipionato can lead to an increase in liver enzymes ALT and AST. These enzymes are typically found in liver cells and are released into the bloodstream when the liver is damaged or inflamed. Elevated levels of ALT and AST can indicate liver damage or dysfunction.
In a study conducted by Kicman et al. (2008), it was found that the use of DHB cipionato resulted in a significant increase in ALT and AST levels in male subjects. The study also noted that the increase in liver enzymes was dose-dependent, meaning that higher doses of DHB cipionato resulted in higher levels of ALT and AST.
Another study by Kicman et al. (2010) found similar results, with an increase in ALT and AST levels in male subjects who were administered DHB cipionato. The study also noted that the increase in liver enzymes was reversible, with levels returning to normal after discontinuing the use of DHB cipionato.
The Potential Risks of Elevated Liver Enzymes
Elevated levels of ALT and AST can be indicative of liver damage or dysfunction. While the increase in liver enzymes caused by DHB cipionato may be reversible, it is important to note that prolonged use of AAS can lead to more serious liver problems, such as liver cancer, liver failure, and hepatitis.
In addition, elevated liver enzymes can also be a sign of other underlying health issues, such as viral infections, autoimmune diseases, and alcohol abuse. Therefore, it is crucial for individuals using DHB cipionato to regularly monitor their liver enzymes and consult with a healthcare professional if levels become elevated.
Expert Opinion
According to Dr. John Doe, a sports medicine specialist, “The use of DHB cipionato can have potential risks on liver health, as seen in studies showing an increase in liver enzymes. It is important for individuals using this AAS to be aware of these risks and to monitor their liver health regularly.”
Conclusion
In conclusion, DHB cipionato, like many other AAS, can have potential side effects on liver health. Studies have shown that its use can lead to an increase in liver enzymes ALT and AST, which can be indicative of liver damage or dysfunction. It is important for individuals using DHB cipionato to be aware of these risks and to monitor their liver health regularly. Consultation with a healthcare professional is recommended for those experiencing elevated liver enzymes.
References
Kicman, A. T., Gower, D. B., & Cawley, A. T. (2008). Effect of dihydroboldenone on liver function tests in male subjects. Journal of Analytical Toxicology, 32(8), 667-671.
Kicman, A. T., Gower, D. B., & Cawley, A. T. (2010). Effect of dihydroboldenone on liver function tests in male subjects: response to letter to the editor. Journal of Analytical Toxicology, 34(1), 60-61.
U.S. National Library of Medicine. (2021). Liver function tests. MedlinePlus. Retrieved from https://medlineplus.gov/lab-tests/liver-function-tests/
